Atlas Trials

E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer

Clinical trial NCT04015336 · TERMINATED

Trial details

NCT number
NCT04015336
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Papillomavirus InfectionsOropharyngeal Neoplasms
Start date
2020-07-06
Primary completion
2020-07-15
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.